Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : McKesson HBOC (MCK) -- Ignore unavailable to you. Want to Upgrade?

To: Bob Howarth who wrote (59)	4/29/1999 6:44:00 PM
From: John M. Gelnieau	Read Replies (1) \| Respond to of 165

MCK was actually worth substantially more in the eyes of the street before the merger. The street has never favored this get together and now that they have slipped they are getting creamed. My gut tells me that any additional restatements will be minimal and all this will clear out about the time the overall markets pull back on the next 12% correction. Also, MCK did not say the revenue would go away but indicated it would be allocated to quarters as it becomes more firm and less contingent. I believe that yesterday discounted the value of the whole damn thing to zero. With that in mind MCK is a good buy for long term hold. It's interesting but I have heard noone discuss, even before the debocle, the distribution strategy that seems to be taking shape leveraging e-commerce initiatives and partnerships.